Home — Division of Infectious Diseases — Farewell 2019…another year of growth for UNMCID

Farewell 2019…another year of growth for UNMCID

2019 continued the theme of growth for our Division of Infectious Diseases. We have added several new faculty to our group (and still actively hiring), continued to redesign the College of Medicine Infectious Diseases curriculum, established a new Community Infectious Diseases service line, expanded our social media presence, joined and led multiple national Infectious Diseases committees, and again hosted the successful regional HIV and Antimicrobial Stewardship conferences. We had a huge presence at #IDWeek2019, with 10 of our faculty either presenting or moderating on the national stage, and many more presenting posters. We are extremely proud of our trainees – the Division supported eight students, residents, and fellows to attend, three of whom gave oral presentations! Finally, we expanded our ID fellowship program and matched three fantastic physicians to join us next summer (with a goal of a final complement of six ID fellows by 2021).

Amidst all of that, our Division was once again among the top publication performers in the Department of Medicine, with our faculty publishing over 70 peer-reviewed journal articles and book chapters crossing several areas of expertise, including HIV, Biopreparedness, Infections in Solid-organ and Stem-cell transplant patients, Antimicrobial Stewardship, Hospital Epidemiology & Infection Control, Diversity & Equity, Social Media, and Infections in critically-ill patients. Curious about the depth and breadth of expertise at UNMC ID? Below is a full list of the publications for your perusal, with convenient links to the referenced articles. It’s long, so consider bookmarking and keep referring to it whenever you need a bit of expertise.

We want to thank Librarian Teresa Hartman (@thartman2u) at the UNMC McGoogan Library for helping us compile this list of publications.

Stay tuned to our blog and follow us on Twitter @UNMC_ID to see all that we have in store for 2020!

2019 UNMC ID Faculty Publications

  1. Abdalla, M. Y., Ahmad, I. M., Rachagani, S., Banerjee, K., Thompson, C. M., Maurer, H. C., . . . Kumar, S. (2019). Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition. Translational Research, 207, 56-69. doi:10.1016/j.trsl.2018.12.008
  2. Aitken, S. L., Nagel, J. L., Abbo, L., Alegria, W., Barreto, J. N., Dadwal, S., . . . Seo, S. K. (2019). Antimicrobial stewardship in patients with cancer: The time is now. JNCCN Journal of the National Comprehensive Cancer Network, 17(7), 772-775. doi:10.6004/jnccn.2019.7318
  3. Anemüller, R., Belden, K., Brause, B., Citak, M., Del Pozo, J. L., Frommelt, L., . . . Zimmerli, W. (2019). Hip and knee section, treatment, antimicrobials: Proceedings of international consensus on orthopedic infections. Journal of Arthroplasty, 34(2), S463-S475. doi:10.1016/j.arth.2018.09.032
  4. Beam, E. L., Schwedhelm, M. M., Boulter, K. C., Vasa, A. M., Larson, L., Cieslak, T. J., . . . Hewlett, A. L. (2019). Ebola virus disease: Clinical challenges, recognition, and management. Nursing Clinics of North America, 54(2), 169-180. doi:10.1016/j.cnur.2019.02.001
  5. Bos, L. D. J., & Kalil, A. C. (2019). Changes in lung microbiome do not explain the development of ventilator-associated pneumonia. Intensive Care Medicine, 45(8), 1133-1135. doi:10.1007/s00134-019-05691-1
  6. Calabrò, F., Coen, M., Franceschini, M., Franco-Cendejas, R., Hewlett, A., Segreti, J., & Senneville, E. (2019). Hip and knee section, treatment, antimicrobial suppression: Proceedings of international consensus on orthopedic infections. Journal of Arthroplasty, 34(2), S483-S485. doi:10.1016/j.arth.2018.09.034
  7. Cawcutt, K. A., Erdahl, L. M., Englander, M. J., Radford, D. M., Oxentenko, A. S., Girgis, L., . . . Silver, J. K. (2019). Use of a coordinated social media strategy to improve dissemination of research and collect solutions related to workforce gender equity. Journal of Women’s Health, 28(6), 849-862. doi:10.1089/jwh.2018.7515
  8. Cawcutt, K. A., Hankins, R. J., Micheels, T. A., & Rupp, M. E. (2019). Optimizing vascular-access device decision-making in the era of midline catheters.Infection. Control and Hospital Epidemiology, 40(6), 674-680. doi:10.1017/ice.2019.49
  9. Cawcutt, K. A., & Kalil, A. C. (2019). Saved from sepsis: Can immunotherapy improve acute and postacute outcomes? Critical Care Medicine, 47(5), 733-735. doi:10.1097/CCM.0000000000003702
  10. Cawcutt, K. A., Marcelin, J. R., & Silver, J. K. (2019). Using social media to disseminate research in infection prevention, hospital epidemiology, and antimicrobial stewardship. Infection Control and Hospital Epidemiology, 40(11), 1262-1268. doi:10.1017/ice.2019.231
  11. Cawcutt, K. A., & Zimmer, A. (2019). Management of infection in patients with kidney transplant. Critical care nephrology: Third edition (pp. 552-560.e1) Elsevier Inc. doi:10.1016/B978-0-323-44942-7.00095-9
  12. Chaisson, R. E., Ramchandani, R., & Swindells, S. (2019). One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis. reply. The New England Journal of Medicine, 381(11), e23. doi:10.1056/NEJMc1908492
  13. Choi, S. -., Britigan, B. E., & Narayanasamy, P. (2019). Dual inhibition of klebsiella pneumoniae and pseudomonas aeruginosa iron metabolism using gallium porphyrin and gallium nitrate. ACS Infectious Diseases, 5(9), 1559-1569. doi:10.1021/acsinfecdis.9b00100
  14. Choi, S. -., Britigan, B. E., & Narayanasamy, P. (2019). Iron/heme metabolism-targeted gallium(III) nanoparticles are active against extracellular and intracellular pseudomonas aeruginosa and acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 63(4) doi:10.1128/AAC.02643-18
  15. Choi, S. -., Britigan, B. E., & Narayanasamy, P. (2019). Treatment of virulent mycobacterium tuberculosis and HIV coinfected macrophages with gallium nanoparticles inhibits pathogen growth and modulates macrophage cytokine production. Msphere, 4(4) doi:10.1128/mSphere.00443-19
  16. Churchyard, G. J., & Swindells, S. (2019). Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB. PLoS Medicine, 16(4) doi:10.1371/journal.pmed.1002787
  17. Cieslak, T. J., Herstein, J. J., Kortepeter, M. G., & Hewlett, A. L. (2019). A methodology for determining which diseases warrant care in a high-level containment care unit. Viruses, 11(9) doi:10.3390/v11090773
  18. El Ramahi, R., & Freifeld, A. (2019). Epidemiology, diagnosis, treatment, and prevention of influenza infection in oncology patients. Journal of Oncology Practice, 15(7), 177-184. doi:10.1200/JOP.19.00350
  19. Endres, J. L., Yajjala, V. K., Fey, P. D., & Bayles, K. W. (2019). Construction of a sequence-defined transposon mutant library in staphylococcus aureus. Humana Press Inc. doi:10.1007/978-1-4939-9570-7_3
  20. Fehring, T. K., Fehring, K. A., Hewlett, A., Higuera, C. A., Otero, J. E., & Tande, A. (2019). What’s new in musculoskeletal infection. Journal of Bone and Joint Surgery – American Volume, 101(14), 1237-1244. doi:10.2106/JBJS.19.00403
  21. Flexner, C., Thomas, D. L., & Swindells, S. (2019). Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitis. Current Opinion in HIV and AIDS, 14(1), 13-20. doi:10.1097/COH.0000000000000510
  22. Florescu, D. F., Schaenman, J. M., & on behalf of the AST Infectious Diseases Community of Practice. (2019). Adenovirus in solid organ transplant recipients: Guidelines from the american society of transplantation infectious diseases community of practice. Clinical Transplantation, 33(9) doi:10.1111/ctr.13527
  23. Florescu, D. F., & Stohs, E. J. (2019). Approach to infection and disease due to adenoviruses in solid organ transplantation. Current Opinion in Infectious Diseases, 32(4), 300-306. doi:10.1097/QCO.0000000000000558
  24. Gandhi, M., Smeaton, L. M., Vernon, C., Scully, E. P., Gianella, S., Poongulali, S., . . . for the Women’s Health Inter-Network Scientific Committee (WHISC). (2019). Low rate of sex-specific analyses in presentations at the conference on retroviruses and opportunistic infections (CROI) meeting, 2018: Room to improve. Journal of Acquired Immune Deficiency Syndromes, 81(5), E158-E160. doi:10.1097/QAI.0000000000002073
  25. Gibbs, S. G., Herstein, J. J., Le, A. B., Beam, E. L., Cieslak, T. J., Lawler, J. V., . . . Lowe, J. J. (2019). Review of literature for air medical evacuation high-level containment transport. Air Medical Journal, 38(5), 359-365. doi:10.1016/j.amj.2019.06.006
  26. Gibbs, S. G., Herstein, J. J., Le, A. B., Beam, E. L., Cieslak, T. J., Lawler, J. V., . . . Lowe, J. J. (2019). Need for aeromedical evacuation high-level containment transport guidelines. Emerging Infectious Diseases, 25(5), 1033-1034. doi:10.3201/eid2505.181948
  27. Gnann, J. W., Jr., Agrawal, A., Hart, J., Buitrago, M., Carson, P., Hanfelt-Goade, D., . . . the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (2019). Lack of efficacy of high-titered immunoglobulin in patients with west nile virus central nervous system disease. Emerging Infectious Diseases, 25(11), 2064-2073. doi:10.3201/eid2511.190537
  28. Hankins, R., Majorant, O. D., Rupp, M. E., Cavalieri, R. J., Fey, P. D., Lyden, E., & Cawcutt, K. A. (2019). Microbial colonization of intravascular catheter connectors in hospitalized patients. American Journal of Infection Control, 47(12), 1489-1492. doi:10.1016/j.ajic.2019.05.024
  29. Havens, J. P., Podany, A. T., Scarsi, K. K., & Fletcher, C. V. (2019). Clinical pharmacokinetics and pharmacodynamics of etravirine: An updated review. Clinical Pharmacokinetics, doi:10.1007/s40262-019-00830-9
  30. Havens, J. P., Scarsi, K. K., Sayles, H., Klepser, D. G., Swindells, S., & Bares, S. H. (2019). Acceptability and feasibility of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis program in the midwestern united states. Open Forum Infectious Diseases, 6(10) doi:10.1093/ofid/ofz365
  31. Hewlett, A. L., Hohenberger, H., Murphy, C. N., Helget, L., Hausmann, H., Lyden, E., . . . Hicks, R. (2019). Evaluation of the bacterial burden of gel nails, standard nail polish and natural nails on the hands of health care workers. [Beurteilung der bakteriellen Belastung von Gelnägeln, Standard-Nagellack und Naturnägel auf den Händen von Gesundheitspersonal] Krankenhaushygiene Und Infektionsverhutung, 41(2), 40-43. doi:10.1016/j.khinf.2019.03.001
  32. Kalil, A. C. (2019). Controversies in nosocomial pneumonias in 2019. Clinical Microbiology and Infection, 25(10), 1171-1172. doi:10.1016/j.cmi.2019.07.003
  33. Kalil, A. C., Gilbert, D. N., Winslow, D. L., Masur, H., & Klompas, M. (2019). Reply to al-hasan and justo. Clinical Infectious Diseases, 68(8), 1432. doi:10.1093/cid/ciy679
  34. Kalil, A. C., Holubar, M., Deresinski, S., & Chambers, H. F. (2019). Is daptomycin plus ceftaroline associated with better clinical outcomes than standard of care monotherapy for staphylococcus aureus bacteremia? Antimicrobial Agents and Chemotherapy, 63(11) doi:10.1128/AAC.00900-19
  35. Kalil, A. C., & Lisboa, T. (2019). To procalcitonin, or not to procalcitonin? Chest, 155(6), 1085-1087. doi:10.1016/j.chest.2019.02.327
  36. Kalil, A. C., & Machado, F. R. (2019). Quick sequential organ failure assessment is not good for ruling sepsis in or out. Chest, 156(2), 197-199. doi:10.1016/j.chest.2019.06.003
  37. Kalil, A. C., & Thomas, P. G. (2019). Influenza virus-related critical illness: Pathophysiology and epidemiology. Critical Care, 23(1) doi:10.1186/s13054-019-2539-x
  38. Kalil, A. C., & Zavascki, A. P. (2019). Can ceftolozane–tazobactam treat nosocomial pneumonia? The Lancet Infectious Diseases, 19(12), 1266-1267. doi:10.1016/S1473-3099(19)30523-7
  39. Keshavjee, S., Amanullah, F., Cattamanchi, A., Chaisson, R., Dobos, K. M., Fox, G. J., . . . Nahid, P. (2019). Moving toward tuberculosis elimination critical issues for research in diagnostics and therapeutics for tuberculosis infection. American Journal of Respiratory and Critical Care Medicine, 199(5), 564-571. doi:10.1164/rccm.201806-1053PP
  40. Kuhn, J. H., Adachi, T., Adhikari, N. K. J., Arribas, J. R., Bah, I. E., Bausch, D. G., . . . Yoti, Z. (2019). New filovirus disease classification and nomenclature. Nature Reviews Microbiology, doi:10.1038/s41579-019-0187-4
  41. Li, X., Gong, W., Wang, H., Li, T., Attri, K. S., Lewis, R. E., . . . Wen, H. (2019). Erratum: O-GlcNAc transferase suppresses inflammation and necroptosis by targeting receptor-interacting Serine/Threonine-protein kinase 3 (immunity (2019) 50(3) (576–590.e6), (S1074761319300305), (10.1016/j.immuni.2019.01.007)). Immunity, 50(4), 1115. doi:10.1016/j.immuni.2019.03.008
  42. Li, X., Gong, W., Wang, H., Li, T., Attri, K. S., Lewis, R. E., . . . Wen, H. (2019). O-GlcNAc transferase suppresses inflammation and necroptosis by targeting receptor-interacting Serine/Threonine-protein kinase 3. Immunity, 50(3), 576-590.e6. doi:10.1016/j.immuni.2019.01.007
  43. Marcelin, J. R., Bares, S. H., & Fadul, N. (2019). Improved infectious diseases physician compensation but continued disparities for women and underrepresented minorities. Open Forum Infectious Diseases, 6(2) doi:10.1093/ofid/ofz042
  44. Marcelin, J. R., Brewer, C., Beachy, M., Lyden, E., Winterboer, T., Murphy, C. N., . . . Van Schooneveld, T. C. (2019). Hardwiring diagnostic stewardship using electronic ordering restrictions for gastrointestinal pathogen testing. Infection Control and Hospital Epidemiology, 40(6), 668-673. doi:10.1017/ice.2019.78
  45. Marcelin, J. R., Manne-Goehler, J., & Silver, J. K. (2019). Supporting inclusion, diversity, access, and equity in the infectious disease workforce. Journal of Infectious Diseases, 220, S50-S61. doi:10.1093/infdis/jiz213
  46. Marcelin, J. R., Siraj, D. S., Victor, R., Kotadia, S., & Maldonado, Y. A. (2019). The impact of unconscious bias in healthcare: How to recognize and mitigate it. Journal of Infectious Diseases, 220, S62-S73. doi:10.1093/infdis/jiz214
  47. Mathur, S., Roberts-Toler, C., Tassiopoulos, K., Goodkin, K., McLaughlin, M., Bares, S., . . . ACTG A5322 Study Team. (2019). Detrimental effects of psychotropic medications differ by sex in aging people with HIV. Journal of Acquired Immune Deficiency Syndromes (1999), 82(1), 88-95. doi:10.1097/QAI.0000000000002100
  48. Mehta, B., Pedro, S., Ozen, G., Kalil, A., Wolfe, F., Mikuls, T., & Michaud, K. (2019). Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: A US national cohort study. RMD Open, 5(1) doi:10.1136/rmdopen-2019-000935
  49. Nailon, R. E., & Rupp, M. E. (2019). Surveillance of home health central venous catheter care outcomes: Challenges and future directions. American Journal of Infection Control, 47(11), 1382-1387. doi:10.1016/j.ajic.2019.04.177
  50. Nailon, R. E., Rupp, M. E., & Lyden, E. (2019). A day in the life of a CVAD. Journal of Infusion Nursing, 42(3), 125-131. doi:10.1097/NAN.0000000000000321
  51. Neary, M., Chappell, C. A., Scarsi, K. K., Nakalema, S., Matovu, J., Achilles, S. L., . . . Lamorde, M. (2019). Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART. The Journal of Antimicrobial Chemotherapy, 74(10), 3003-3010. doi:10.1093/jac/dkz298
  52. Neemann, K., Olateju, E. K., Izevbigie, N., Akaba, G., Olanipekun, G. M., Richard, J. C., . . . Obaro, S. (2019). Neonatal outcomes associated with maternal recto-vaginal colonization with extended-spectrum β-lactamase producing enterobacteriaceae in nigeria: A prospective, cross-sectional study. Clinical Microbiology and Infection, doi:10.1016/j.cmi.2019.07.013
  53. O’Horo, J. C., & Cawcutt, K. A. (2019). Critical care viral infections. Critical care nephrology: Third edition (pp. 560-567.e1) Elsevier Inc. doi:10.1016/B978-0-323-44942-7.00096-0
  54. O’Horo, J. C., Marcelin, J. R., Saleh, O. M. A., Barwise, A. K., Odean, P. M., Rivera, C. G., . . . Tosh, P. K. (2019). Standardizing febrile neutropenia management: Antimicrobial stewardship in the hematologic malignancy population. Journal of Oncology Practice, 15(9), E843-E848. doi:10.1200/JOP.18.00775
  55. Patel, R. C., Stalter, R. M., Thomas, K. K., Tamraz, B., Blue, S. W., Erikson, D. W., . . . Scarsi, K. K. (2019). A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in kenya and uganda. Aids, 33(13), 1995-2004. doi:10.1097/QAD.0000000000002308
  56. Rawizza, H. E., Darin, K. M., Oladokun, R., Brown, B., Ogunbosi, B., David, N., . . . Kanki, P. J. (2019). Safety and efficacy of rifabutin among HIV/TB-coinfected children on lopinavir/ritonavir-based ART. Journal of Antimicrobial Chemotherapy, 74(9), 2707-2715. doi:10.1093/jac/dkz219
  57. Rearigh, L., Kedar, S., & Bares, S. H. (2019). Uveomeningeal syndrome in a healthy, young male: An unusual presentation of west nile virus. Journal of Neurovirology, doi:10.1007/s13365-019-00808-0
  58. Reed, H. L., Van Schooneveld, T. C., Reha, C. G., & Bergman, S. J. (2019). Use of a best practice alert linking clostridioides difficile infection test results to a severity-based treatment order set. Infection Control and Hospital Epidemiology, 40(4), 467-469. doi:10.1017/ice.2019.18
  59. Reinecke, J., Lowas, S., Snowden, J., & Neemann, K. (2019). Blood stream infections and antibiotic utilization in pediatric leukemia patients with febrile neutropenia. Journal of Pediatric Hematology/Oncology, 41(4), 251-255. doi:10.1097/MPH.0000000000001279
  60. Scarsi, K. K., Cramer, Y. S., Rosenkranz, S. L., Aweeka, F., Berzins, B., Coombs, R. W., . . . AIDS Clinical Trials Group A5316 Study Team. (2019). Antiretroviral therapy and vaginally administered contraceptive hormones: A three-arm, pharmacokinetic study. The Lancet HIV, 6(9), e601-e612. doi:10.1016/S2352-3018(19)30155-9
  61. Schmitt, S., Macintyre, A. T., Bleasdale, S. C., Ritter, J. T., Nelson, S. B., Berbari, E. F., . . . McQuillen, D. P. (2019). Early infectious diseases specialty intervention is associated with shorter hospital stays and lower readmission rates: A retrospective cohort study. Clinical Infectious Diseases, 68(2), 239-246. doi:10.1093/cid/ciy494
  62. Schreier, T., Sherer, R., Sayles, H., Jacobsen, D. M., Swindells, S., & Bares, S. H. (2019). US human immunodeficiency virus (HIV) practitioners’ recommendations regarding condomless sex in the era of HIV pre-exposure prophylaxis and treatment as prevention. Open Forum Infectious Diseases, 6(3) doi:10.1093/ofid/ofz082
  63. Schully, K. L., Young, C. C., Mayo, M., Connolly, A. L., Rigas, V., Spall, A., . . . Currie, B. J. (2019). Next-generation diagnostics for melioidosis: Evaluation of a prototype i-STAT cartridge to detect burkholderia pseudomallei biomarkers. Clinical Infectious Diseases, 69(3), 421-427. doi:10.1093/cid/ciy929
  64. Shillcutt, S.K., Md,Ms, Fase, Arnzen, A., Md, & Cawcutt, K.,Md, Ms. (2019). Bridging the gender gap in critical care practice. International Anesthesiology Clinics, 57(2), 132-143. doi:10.1097/AIA.0000000000000223
  65. Spector, N. D., Asante, P. A., Marcelin, J. R., Poorman, J. A., Larson, A. R., Salles, A., . . . Silver, J. K. (2019). Women in pediatrics: Progress, barriers, and opportunities for equity, diversity, and inclusion. Pediatrics, 144(5) doi:10.1542/peds.2019-2149
  66. Stohs, E., Chow, V. A., Liu, C., Bourassa, L., Miles-Jay, A., Knight, J., . . . Pergam, S. A. (2019). Limited utility of outpatient surveillance blood cultures in hematopoietic cell transplant recipients on high-dose steroids for treatment of acute graft-versus-host-disease. Biology of Blood and Marrow Transplantation, 25(6), 1247-1252. doi:10.1016/j.bbmt.2019.01.031
  67. Sweeney, D. A., & Kalil, A. C. (2019). Why don’t we have more inhaled antibiotics to treat ventilator-associated pneumonia? Clinical Microbiology and Infection, 25(10), 1195-1199. doi:10.1016/j.cmi.2019.04.018
  68. Swindells, S., Ramchandani, R., Gupta, A., Benson, C. A., Leon-Cruz, J., Mwelase, N., . . . Chaisson, R. E. (2019). One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis. New England Journal of Medicine, 380(11), 1001-1011. doi:10.1056/NEJMoa1806808
  69. Tan, E. M., Agarwal, S. K., Marcelin, J. R., & Virk, A. (2019). Rabies pre-exposure prophylaxis: A 10-year experience of vaccination in international travelers. Travel Medicine and Infectious Disease, 28, 102-103. doi:10.1016/j.tmaid.2018.07.003
  70. Tan, E. M., Marcelin, J. R., & Virk, A. (2019). Pre-travel counseling for immunocompromised travelers: A 12-year single-center retrospective review. Infection, Disease and Health, 24(1), 13-22. doi:10.1016/j.idh.2018.09.083
  71. Timsit, J. -., Sonneville, R., Kalil, A. C., Bassetti, M., Ferrer, R., Jaber, S., . . . Van Delden, C. (2019). Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients. Intensive Care Medicine, 45(5), 573-591. doi:10.1007/s00134-019-05597-y
  72. Weld, E. D., Rana, M. S., Dallas, R. H., Camacho-Gonzalez, A. F., Ryscavage, P., Gaur, A. H., . . . Agwu, A. L. (2019). Interest of youth living with HIV in long-acting antiretrovirals. Journal of Acquired Immune Deficiency Syndromes, 80(2), 190-197. doi:10.1097/QAI.0000000000001896
  73. Zhou, C., Bhinderwala, F., Lehman, M. K., Thomas, V. C., Chaudhari, S. S., Yamada, K. J., . . . Fey, P. D. (2019). Urease is an essential component of the acid response network of staphylococcus aureus and is required for a persistent murine kidney infection. PLoS Pathogens, 15(1) doi:10.1371/journal.ppat.1007538
  74. Zimmer, A. J., & Freifeld, A. G. (2019). Optimal management of neutropenic fever in patients with cancer. Journal of Oncology Practice, 15(1), 19-24. doi:10.1200/JOP.18.00269

Leave a comment

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe

AygHE DTa eyZ c H
Work at UNMC
Get Directions
Apply